ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,641Medicare Part D Prescriptions Filled, Including Refills

Rank: 154 out of 3001

$946K Total Retail Price of All Prescriptions

Rank: 126 out of 3001

558 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,507 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 598 468 1 2
OMEPRAZOLE 533 346 2 4
AMLODIPINE BESYLATE 462 385 3 5
SIMVASTATIN 445 340 4 1
ATORVASTATIN CALCIUM 310 249 5 11
FUROSEMIDE 296 236 6 6
ATENOLOL 293 235 7 18
ZOLPIDEM TARTRATE 235 135 8 24
LOSARTAN POTASSIUM 228 163 9 21
HYDROCHLOROTHIAZIDE 228 156 9 10
PRAVASTATIN SODIUM 225 150 11 13
OXYCODONE-ACETAMINOPHEN 219 140 S2 12 32
METOPROLOL TARTRATE 214 149 13 8
LEVOTHYROXINE SODIUM 202 159 14 3
METFORMIN HCL ER 193 143 15 51
TRAMADOL HCL 185 138 16 17
GABAPENTIN 171 158 17 14
HYDROCODONE-ACETAMINOPHEN 167 123 S3 18 7
METFORMIN HCL 166 105 19 9
LEVOFLOXACIN 165 123 20 115
CITALOPRAM HBR 163 98 21 16
GLIMEPIRIDE 148 80 22 31
METOPROLOL SUCCINATE 146 122 23 19
POTASSIUM CHLORIDE 140 118 24 15
NIFEDIPINE ER 139 116 25 154
AZITHROMYCIN 132 75 26 36
SPIRIVA 123 91 27 57
PROAIR HFA 115 46 28 30
JANUVIA 111 83 29 54
ADVAIR DISKUS 110 78 30 58
CRESTOR 108 82 31 33
TIZANIDINE HCL 105 54 32 101
AMLODIPINE BESYLATE-BENAZEPRIL 101 37 33 78
BYSTOLIC 97 63 34 137
KLOR-CON M20 92 68 35 52
BUPROPION HCL SR 90 49 36 190
LIPITOR 89 67 37 100
LANTUS SOLOSTAR 88 53 38 80
ALENDRONATE SODIUM 88 70 38 26
NEXIUM 86 39 40 23
WARFARIN SODIUM 85 74 41 12
NIFEDICAL XL 82 70 42 269
ALPRAZOLAM 82 46 42 98
CEPHALEXIN 80 50 44 86
TRAZODONE HCL 78 42 45 37
CLOPIDOGREL 77 48 46 28
FINASTERIDE 76 68 47 92
INSULIN SYRINGE 74 61 48 162
CLONIDINE HCL 72 56 49 64
LYRICA 71 33 50 87
CYMBALTA 71 35 50 53
MELOXICAM 69 47 52 34
LANTUS 69 55 52 47
ALLOPURINOL 66 58 54 35
BUMETANIDE 66 54 54 151
HUMULIN 70-30 65 53 56 423
SUCRALFATE 65 41 56 164
DIGOXIN 65 62 56 65
AMITRIPTYLINE HCL 63 52 R 59 85
ZETIA 63 53 59 69
ISOSORBIDE MONONITRATE ER 62 59 61 45
CARVEDILOL 61 51 62 25
CEFADROXIL 61 46 62 430
CYCLOBENZAPRINE HCL 60 32 R 64 73
VERAPAMIL ER 60 48 64 102
NYSTATIN-TRIAMCINOLONE 60 43 64 248
FLUOXETINE HCL 60 39 64 61
ONGLYZA 57 40 68 211
NAPROXEN 57 35 68 84
LOVAZA 57 48 68 168
PEN NEEDLE 57 41 68 128
DONEPEZIL HCL 56 56 72 27
PLAVIX 56 39 72 46
FLUCONAZOLE 55 31 74 194
POLYETHYLENE GLYCOL 3350 55 41 74 55
FLUTICASONE PROPIONATE 54 39 76 42
BUSPIRONE HCL 54 49 76 91
ROPINIROLE HCL 53 39 78 88
PIROXICAM 53 40 78 350
DILTIAZEM 24HR ER 53 45 78 131
PAROXETINE HCL 52 35 81 60
NOVOLIN 70-30 52 50 81 208
CLONAZEPAM 52 15 81 259
PRILOSEC OTC 51 46 84 328
LOSARTAN-HYDROCHLOROTHIAZIDE 50 41 85 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.